Phosphodiesterase inhibitor
Showing 1 - 25 of 7,660
Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)
Active, not recruiting
- Erectile Dysfunction Following Radiation Therapy
- +2 more
- P shot arm ( Autologous Platelet Rich Plasma)
- PDE5i arm
-
Mansoura, Outside U.S./Canada, EgyptMansoura urology and nephrology center
Mar 15, 2023
Schizophrenia Trial in Shibin Al Kawm (Placebo oral tablet, Pentoxifylline)
Completed
- Schizophrenia
- Placebo oral tablet
- Pentoxifylline
-
Shibīn Al Kawm, EgyptFaculty of Medicine
Oct 23, 2022
MDD Trial in Shibeen Elkom (Roflumilast 250Mcg Tab, Placebo)
Recruiting
- Major Depressive Disorder
- Roflumilast 500Mcg Tab
- Placebo
-
Shibeen Elkom, Menoufia, EgyptFaculty of Pharmacy
Jan 16, 2023
MDD Trial in Shibin Al Kawm (Sildenafil Citrate, Placebo oral tablet)
Recruiting
- Major Depressive Disorder
- Sildenafil Citrate
- Placebo oral tablet
-
Shibīn Al Kawm, EgyptFaculty of Medicine
Jan 16, 2023
Phosphodiesterase Type 5 Inhibitor to Improve Anabolic
Not yet recruiting
- Sarcopenia
- Tadalafil 5mg
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Jul 25, 2022
Osteoarthritis Trial in Shibin Al Kawm (Cilostazol 50 MG, Placebo)
Recruiting
- Osteoarthritis
- Cilostazol 50 MG
- Placebo
-
Shibīn Al Kawm, Menoufia, EgyptFaculty of Pharmacy
Jul 28, 2022
Alcohol, Phosphodiesterase Inhibitor, Erectile Dysfunction Trial in Shanghai (TPN171H tablet plus alcohol, alcohol, TPN171H
Completed
- Alcohol
- +2 more
- TPN171H tablet plus alcohol
- +2 more
-
Shanghai, ChinaShanghai Xuhui Central Hospital
May 20, 2022
Congenital Diaphragmatic Hernia, Pulmonary Hypertension Trial in Salt Lake City (Sildenafil Oral Suspension, Placebo)
Not yet recruiting
- Congenital Diaphragmatic Hernia
- Pulmonary Hypertension
- Sildenafil Oral Suspension
- Placebo
-
Salt Lake City, UtahPrimary Children's Hospital
Jan 27, 2022
Erectile Dysfunction, Sexual Dysfunction Trial in Salt Lake City (Natesto Nasal Product, Placebo)
Recruiting
- Erectile Dysfunction
- Sexual Dysfunction
- Natesto Nasal Product
- Placebo
-
Salt Lake City, UtahUniversity of Utah, Division of Urology
Aug 11, 2022
Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity Trial in Guangzhou (Crisaborole Ointment, Cetuximab)
Recruiting
- Metastatic Colorectal Cancer
- +2 more
- Crisaborole Ointment
- Cetuximab
-
Guangzhou, Guangdong, ChinaWeiWei Xiao
Nov 3, 2023
Chronic Sinusitis Trial in Shibin Al Kawm (Roflumilust, Prednisolone)
Not yet recruiting
- Chronic Sinusitis
-
Shibīn Al Kawm, Menoufia, EgyptMenoufia Faculty of Medicine
May 5, 2022
MDD Trial in Shibin Al Kawm (Tadalafil 5Mg Tab, Placebo)
Recruiting
- Major Depressive Disorder
- Tadalafil 5Mg Tab
- Placebo
-
Shibīn Al Kawm, Menoufia, EgyptFaculty of Pharmacy
Aug 31, 2021
Sickle Cell People With Pulmonary Hypertension
Completed
- Pulmonary Hypertension
- Sickle Cell Disease
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Apr 16, 2021
Discoid Lupus Erythematosus Trial in New York (CC-10004)
Completed
- Discoid Lupus Erythematosus
-
New York, New YorkNew York University Tisch Hospital
Feb 10, 2021
Lichen Planus of Vulva, Female Genital Disease Trial in Oslo (Apremilast, Placebo)
Recruiting
- Lichen Planus of Vulva
- Female Genital Disease
- Apremilast
- Placebo
-
Oslo, NorwayOslo University Hospital HF
Aug 22, 2021
Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy, Pseudohypoparathyroidism Type 1a Trial in Nashville (Theophylline,
Recruiting
- Pseudohypoparathyroidism
- +2 more
- Theophylline
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 4, 2022
Fundus Oculi and Erectile Dysfunction
Unknown status
- Erectile Dysfunction
- Dynamic Vessel Analyzer (DVA)
- Phosphodiesterase type 5 Inhibitor (PDE5I)
-
Milan, MI, ItalyOspedale San Raffaele
Jul 20, 2020
Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy Trial in Nashville (Theophylline, Placebos)
Recruiting
- Pseudohypoparathyroidism
- Albright Hereditary Osteodystrophy
- Theophylline
- Placebos
-
Nashville, TennesseeAshley Shoemaker
Aug 15, 2022
MDD Trial in Erbil (Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg, Citalopram (tablet) 20 mg + Placebo (tablet))
Completed
- Major Depressive Disorder
- Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg
- Citalopram (tablet) 20 mg + Placebo (tablet)
-
Erbil, IraqHawler Psychiatric Hospital and Private Clinic
Mar 16, 2022
Dosimetry, Healthy Trial run by the NIMH ([C-11](R)-rolipram)
Completed
- Dosimetry
- Healthy
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019